Position in NSRX
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$3,500
-$940 QoQ
Shares Held
1,000
-50.0% QoQ
Ownership
0.009%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#9
of 10 holders
Holding Since
Sep 2025
4 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in NSRX Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026MORGAN STANLEY holds $63,698,443,803 across 20 Drug Manufacturers - General names. NSRX ranks #19 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
16,226,398 | $19,462,430,163 | |
| 2 | JNJ |
Johnson & Johnson
|
44,808,254 | $11,379,952,259 | |
| 3 | ABBV |
AbbVie Inc.
|
38,901,001 | $9,789,047,884 | |
| 4 | MRK |
Merck & Co., Inc.
|
48,641,158 | $6,250,388,797 | |
| 5 | AMGN |
Amgen Inc
|
13,653,692 | $4,944,274,940 | |
| 6 | GILD |
Gilead Sciences, Inc.
|
24,004,354 | $3,032,710,073 | |
| 7 | PFE |
Pfizer Inc
|
96,345,452 | $2,319,998,477 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
29,009,025 | $1,671,500,010 |
All Filings in NSRX
Export CSV
4 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $3,500 | 1,000 | Shares | Defined | 2026-08-13 | |
| 2026-03-31 | $4,440 | 2,000 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $18,300 | 2,000 | Shares | Defined | 2026-05-27 | |
| 2025-09-30 | $13,300 | 2,000 | Shares | Defined | 2026-05-27 | |
| No filing history on record for this holder in this stock. | ||||||